Clinical Trials Browser

Phase 4 × bicalutamide × 90 days × Clear all

NCT05700903 2026-03-02

ARCH

Phase 4 Completed

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias